Heavy chain only antibodies: A new paradigm in personalized HER2+ breast cancer therapy

Seyed Moghimi, Fatemeh Rahbarizadeh, Davoud Ahmadvand, Ladan Parhamifar

Research output: Contribution to journalEditorial

11 Scopus citations

Fingerprint Dive into the research topics of 'Heavy chain only antibodies: A new paradigm in personalized HER2+ breast cancer therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds